Metabologenomics

Metabologenomics is a joint venture founded by researchers from Keio University and Tokyo Institute of Technology that develops gut-environment assessment tools to enable personalized gut design aimed at disease prevention. It analyzes individuals' stool samples using its proprietary Metabologenomics technique to profile the gut environment and support stratified healthcare and medical care based on gut environment types. In May 2019 the company launched a Next-Generation Gut Environment Assessment Service for corporate and clinical customers using an original stool sampling kit.